# IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy

> **NCT07235813** · NA · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 16 (actual)

## Conditions studied

- Mycosis Fungoides

## Interventions

- **RADIATION:** Phototherapy (PUVA or NB-UVB)

## Key facts

- **NCT ID:** NCT07235813
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-07-06
- **Final completion:** 2025-10-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07235813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07235813, "IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07235813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*